# Entacapone Augmentation for Schizophrenia

> **NCT00192855** · NA · COMPLETED · sponsor: **Rambam Health Care Campus** · enrollment: 52 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Entacapone

## Key facts

- **NCT ID:** NCT00192855
- **Lead sponsor:** Rambam Health Care Campus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2006-10
- **Final completion:** 2006-10
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2010-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00192855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00192855, "Entacapone Augmentation for Schizophrenia". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00192855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*